Skip to main content

Table 4 Description of allergen specific antibodies, before, 1, 2 and 3 years of allergen immunotherapy

From: Treatment with pollen allergen immunotherapy improves health-related quality of life in children and adolescents: a three-year follow-up-study

Allergen antibodies (kUA/L, g/L)

Base mean (95% CI)

One year mean (95% CI)

Two years mean (95% CI)

Three years mean (95% CI)

p value

IgE birch,

151.0 (113.5–188.6) n = 134

99.4 (77.9–120.8) n = 117

88.1 (66.2–110.0) n = 104

76.8 (57.0–96.7) n = 109

 < 0.001

IgG4 birch

2.2 (0.9–3.4) n = 93

8.8 (6.9–10.7) n = 85

15.0 (12.2–17.9) n = 75

17.6 (14.8–20.5) n = 70

 < 0.001

IgE grass

37.8 (4.9–70.8) n = 22

22.0 (8.8–35.2) n = 18

20.8 (7.5–34.2) n = 18

16.8 (5.9–27.6) n = 18

0.070

IgG4 grass

0.5 (0.1–0.9) n = 21

12.9 (8.1–17.7) n = 17

15.3 (8.5–22.2) n = 17

14.3 (7.5–21.1) n = 17

 < 0.001

  1. Repeated measures ANOVA